VuCOMP to Showcase Industry Leading Computer Vision Systems for the Detection of Breast Cancer at RSNA 2014
Share:
PLANO, Texas — VuCOMP, Inc., leading developer of advanced computer vision systems for the detection of breast cancer, today announced that it will be showcasing its portfolio of cutting-edge imaging products at the 100(th) Scientific Assembly and Annual Meeting of the Radiological Society of North America (RSNA) at McCormick Place, Chicago from November 30(th) through December 4th. The meeting attracts over 60,000 medical imaging professionals from around the world.
"RSNA provides an unparalleled opportunity to demonstrate, to the world's largest gathering of the radiology community, the latest features of our product line, as well as share what we have been developing throughout the year," said Jim Pike, President and CTO of VuCOMP. "We are looking forward to another outstanding exhibition."
VuCOMP will be highlighting the latest enhancements to the M-Vu® System, as well as a works-in-progress CAD solution for 3D breast tomosynthesis.
M-Vu CAD for mammography is the first mammography CAD proven effective in an FDA-approved reader study. The latest advancements, M-Vu CAD version 3.0 and 3.1, provide radiologists with a substantial reduction in false positive marks and a lower false positive rate while improving sensitivity.
Breast density notification continues to gain momentum as now nineteen states require that physicians notify women of their breast density following their mammogram. In addition, federal legislation has been introduced and is pending. M-Vu Breast Density is designed to advance the science of automated breast density assessment. M-Vu Breast Density Version 2.0 adds a critical dimension to the analysis of dense breast tissue. The VuCOMP density category, analogous to the BI-RADS breast density composition category, is now correlated to not only the amount, but also the distribution - the actual dispersion - of fibroglandular tissue providing radiologists with a consistent and accurate result.
In addition, 3D tomosynthesis has continued to gain widespread acceptance, and with that comes the need for a CAD solution specifically designed to analyze the vast amount of information that tomosynthesis provides. VuCOMP engineers have been working diligently on a cutting-edge solution that is designed to identify regions of interest that are consistent with breast cancer. Ultimately, providing the radiologist with another tool precisely designed for 3D tomosynthesis. At RSNA 2014, VuCOMP will display its latest works-in-progress version of this technology.
Phil Evans, MD, FACR, Clinical Professor of Radiology, Director of the Center for Breast Care at UT Southwestern Medical Center commented, "Because very subtle changes in breast architecture may be identified utilizing tomosynthesis, computer-aided detection is likely to play an even greater role here than with 2-D mammography."
To learn more please visit VuCOMP at RSNA 2014, Booth# 4172, South Hall, McCormick Place or visit www.vucomp.com.
About VuCOMP, Inc.
VuCOMP, Inc. leads the way in setting a new standard for CAD and automated breast density measurement. The company is dedicated exclusively to developing advanced cancer detecting technologies. VuCOMP's engineering team has worked together since 1986, pioneering some of the world's most advanced computer vision systems. For more information, please visit www.vucomp.com.
SOURCE VuCOMP, Inc.
CONTACT:
Dan Conley
Beacon Communications
312-593-8461
dconley@beaconpr.com
Web Site: http://www.vucomp.com
